Cannabidiol + Dronabinol for opioid-related disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Aug 2025: Trial registered, NCT07148206

The trials

NCT07148206: Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial

State
Not started
Phase
Phase 3
People
40 planned
Started
Oct 2026
Primary completion
May 2028
Arms
Dronabinol + Epidiolex Arm
Results
None posted
  1. 29 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.